Симуляция графика K-линий, фактические данные указаны на торговой странице
Ключевые данные
Открытие вчера
$4.75
Пред. закрытие
$5.58
Вчерашний диапазон
$4.51 - $5.72
Диапазон 52 нед.
$2.21 - $14.21
Объем торговли
270.538K
МС
$45.412M
P/E
--
EPS
$-23.01
Обзор компании
NASDAQ
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.
СекторHEALTHCARE
ОтрасльBIOTECHNOLOGY
Штаб-квартира18706 NORTH CREEK PARKWAY, BOTHELL, WA, UNITED STATES, 98011
LONA operates within the [sector] sector and is focused on [core business]. Its main activity involves [core business details], which positions it as a significant player in its industry.
LONA generates most of its revenue from [main revenue drivers], leveraging its expertise in [sector/industry]. This focus allows the company to maintain a competitive edge and sustain financial performance.
As with any investment, there are risks. For LONA, these could include [list key risks, e.g., industry volatility, competition, regulatory impacts]. Investors should carefully evaluate these factors before making decisions.
LONA competes with companies such as [competitor names], distinguishing itself through [specific strengths, e.g., product offering, market share]. However, competition remains strong, posing challenges and opportunities.
Yes/No, LONA [does/does not] pay dividends. Its dividend policy reflects [focus on reinvestment, income distribution]. Investors interested in dividend income should consider this when evaluating the company.
LONA has opportunities in [growth areas, e.g., emerging markets, new technologies]. By leveraging [its strengths], the company is positioned to capitalize on sector trends, though risks remain.
LONA's financial performance may be influenced by [factors such as economic conditions, shifts in demand, input costs]. External and internal elements both play a role in its profitability and overall operations.
Based on current market data, LONA's valuation metrics such as P/E ratio, market cap, and revenue are in line with/above/below its peers like [competitor names]. Valuation reflects both strengths and market challenges.
Предупреждение о рисках
1.Цены на акции могут сильно колебаться, инвестируйте осторожно. Прошлые результаты не гарантируют будущую доходность.
2.Торговля цифровыми активами сопряжена с рыночными, техническими и иными рисками. Пожалуйста, принимайте взвешенные решения и рационально распределяйте активы.
3.Информация на этой странице предназначена только для ознакомления и не является инвестиционной рекомендацией.